JK07 not checked

Salubris Biotherapeutics Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
None yet
 
Trials
1 active
4 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“JK07 is a fully human anti-human epidermal growth factor receptor 3 (also known as ErbB3 or HER3) antibody fused with the epidermal growth factor (EGF)-domain of Neuregulin (NRG)-1b protein.”In the company’s words, NCT06369298 on ClinicalTrials.gov
Tested for
Heart Failure With Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction
Main trialPhase 2
“This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.”In the company’s words, NCT06369298 on ClinicalTrials.gov

Other drugs for Heart Failure With Reduced Ejection Fraction

All 42 drugs for Heart Failure With Reduced Ejection Fraction

Coming up0

No dates coming up.

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 2Active, not recruiting 31 Oct 2026 Study of JK07 in Patients With Chronic Heart Failure
Phase 2Withdrawn 16 Apr 2026 Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
Phase 1Withdrawn 26 May 2023 Single-Ascending Dose Study of JK07 in Subjects With HFpEF
Phase 1Completed 8 Jun 2023 Study of JK07 in Subjects With Heart Failure With Reduced Ejection Fraction (HFrEF)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow JK07

Following is part of Solo: you see every change to JK07 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in